Racial, Ethnic, and Sex-based Disparities among High-risk Individuals Undergoing Pancreatic Cancer Surveillance
Authors:
- Bryson W. KatonaBKBryson W. Katona
- Kelsey KluteKKKelsey Klute
- Randall E. BrandRBRandall E. Brand
- Jessica N. EverettJEJessica N. Everett
- James J. FarrellJFJames J. Farrell
- Kieran HawthorneKHKieran Hawthorne
- Vivek KaulVKVivek Kaul
- Sonia S. KupferSKSonia S. Kupfer
- Salvatore PaiellaSPSalvatore Paiella
- Diane M. SimeoneDSDiane M. Simeone
- Daniel A. SussmanDSDaniel A. Sussman
- George ZogopoulosGZGeorge Zogopoulos
- 1 June 2023
- journal article
- research article
- Published by American Association for Cancer Research (AACR) in Cancer Prevention Research
- Vol. 16 (6) , 343-352
Abstract
Since its inception two years ago, the international, multicenter Pancreatic Cancer Early Detection (PRECEDE) Consortium has enrolled high-risk individuals (HRI) undergoing pancreatic ductal adenocarcinoma (PDAC) surveillance. Herein we aim to evaluate enrollment disparities in PRECEDE. Data on HRIs enrolled between May 2020 and March 2022 were collected, with HRIs defined as participants enrolled in PRECEDE meeting guideline-based criteria for PDAC surveillance. Of 1,273 HRIs enrolled, 1,113 were eligible for inclusion, with 47.2% meeting familial pancreatic cancer criteria without a known pathogenic variant (PV) and the remainder having a pathogenic variant in a PDAC-risk gene (CDKN2A, STK11, PRSS1, BRCA1, BRCA2, PALB2, ATM, MLH1, MSH2, MSH6, PMS2, or EPCAM). Study participants were predominantly from the United States (82.7%), the most common age range at enrollment was 60–69 years (37.4%), and a non-PDAC cancer was present in 32.4%. There were racial/ethnic- and sex-based disparities among enrolled subjects, as the majority of participants were female (65.9%) and self-reported white (87.7%), with only 2.9% having Hispanic ethnicity. While more than 97% of participants consented to utilize imaging data and biosamples for research, there was no difference in rate of consent based on race/ethnicity, sex, or age, thereby demonstrating uniform participation in research activities among all subgroups after enrollment. Ensuring that diversity of HRIs in PDAC surveillance programs mirrors the communities served by participating centers is important. Substantial racial/ethnic- and sex-based disparities persist among recently enrolled HRIs undergoing PDAC surveillance, and therefore reducing these disparities will be a major focus of the PRECEDE Consortium moving forward. Prevention Relevance: Pancreatic cancer surveillance is critical to decreasing pancreatic cancer mortality; therefore, it is important that pancreatic cancer surveillance studies enroll diverse patients. We demonstrate that substantial racial/ethnic- and sex-based disparities exist amongst enrollment in the international PRECEDE consortium, highlighting the dire need for future efforts to reduce these disparities. See related Spotlight, p. 305Keywords
All Related Versions
Funding Information
- Smith Family Research Fund
- Basser Center for BRCA
- Project Purple
- Trovanow
This publication has 31 references indexed in Scilit:
- Pancreatic Cancer Surveillance: Who, When, and HowCurrent Treatment Options in Gastroenterology, 2019
- Management of patients with increased risk for familial pancreatic cancer: updated recommendations from the International Cancer of the Pancreas Screening (CAPS) ConsortiumGut, 2019
- Screening for Pancreatic CancerJAMA, 2019
- Genetics of Familial and Sporadic Pancreatic CancerGastroenterology, 2019
- Evaluating Susceptibility to Pancreatic Cancer: ASCO Provisional Clinical OpinionJournal of Clinical Oncology, 2019
- Risk of Neoplastic Progression in Individuals at High Risk for Pancreatic Cancer Undergoing Long-term SurveillanceGastroenterology, 2018
- Prevalence of germ-line mutations in cancer genes among pancreatic cancer patients with a positive family historyGenetics in Medicine, 2017
- Benefit of Surveillance for Pancreatic Cancer in High-Risk Individuals: Outcome of Long-Term Prospective Follow-Up Studies From Three European Expert CentersJournal of Clinical Oncology, 2016
- ACG Clinical Guideline: Genetic Testing and Management of Hereditary Gastrointestinal Cancer SyndromesAmerican Journal of Gastroenterology, 2015
- Racial and Gender Disparities in Hereditary Colorectal Cancer Risk Assessment: The Role of Family HistoryJournal of Cancer Education, 2006